About us > Our History


Our History

Seqalis™ is a new trademark of BIO.be S.A. since June 2022. This underlines an important milestone in the 19-year history of the company. The name embodies the concepts of Service, Quality Assurance and Life Sciences.

This change emphasises our strong willingness to further reinforce our unique expertise and analytical service offering in Anatomical Pathology, Cytogenetics and Molecular Biology through technological and scientific advances in the Life Sciences markets. With our clients, we aim to speed up scientific progress through innovative ideas and paradigm shifts by adapting our technologies to make this step achievable.

The recent launch of our new quantitative TCR sequencing platform for monitoring the immune response of patients in the rapidly growing field of personalised medicine is one of numerous examples.

Seqalis™ will also keep on intensively cross-pollinating with its mother company, the Institute of Pathology and Genetics (IPG), one of the eight Belgian Genetics Centres, to continuously foster innovation in the medical and diagnostic fields.

1958

Creation of the Institute of Pathology and Genetics (IPG)

1968

Creation of the IPG Human Genetics Centre

2000

Creation of the forensic laboratory (stopped in 2016)

2003

Creation of BIO.be

2006

Move to the Gosselies facility (10,000 m2)

2009

Creation of a biobank for human biological samples

2012

Shareholding in OncoDNA S.A.

2013

 Launch of a new services portfolio in Molecular Biology, Anatomic-Pathology and Cytogenetics

2021

New NGS services (WES, RNAseq, WGS)

2022

Creation of Seqalis
Launch of Immune Monitoring services

Doctors and scientists can help you.

©   Seqalis™, a BIO.be company trademark - All rights reserved. Design by Oblique.